Vitamin B6 metabolic pathway (None (the pathway itself does not have a standard abbreviation; the active coenzyme is commonly abbreviated as PLP for pyridoxal 5'-phosphate[8][1]).)

The vitamin B6 metabolic pathway, also known as pyridoxine metabolism, encompasses all biochemical reactions involved in the absorption, phosphorylation, interconversion, utilization, and degradation of vitamin B6 vitamers—primarily pyridoxal (PL), pyridoxamine (PM), and pyridoxine (PN)—and their phosphorylated forms including pyridoxal phosphate (PLP) which serves as the biologically active coenzyme form. Mammals cannot synthesize PLP de novo but convert dietary PN/PM/PL into their respective phosphates via pyridoxal kinase, then further interconvert PNP/PMP into PLP using PNPOX/PMP oxidase, forming a salvage cycle critical for maintaining cellular pools of active cofactor[3][1]. PLP acts as an essential coenzyme for over one hundred different enzymatic reactions—most notably those involved in amino acid transamination/decarboxylation/racemization; neurotransmitter biosynthesis including serotonin/dopamine/GABA/histamine; hemoglobin synthesis via ALA synthase; sphingolipid biosynthesis; glycogen breakdown via glycogen phosphorylase; tryptophan-to-niacin conversion through kynureninase activity—and modulates gene expression through effects on transcription factors and mRNA stability[1][2][4]. Disruption at any step can lead to diverse clinical consequences ranging from neurological symptoms such as seizures or cognitive impairment to hematologic abnormalities like microcytic anemia or immune dysfunction due to impaired lymphocyte proliferation/functionality[5][7]. Because it represents an entire network rather than a discrete molecular entity amenable to direct pharmacological targeting, "vitamin B6 metabolic pathway" should not be considered a canonical therapeutic target but instead describes essential biochemistry underpinning many physiological processes and disease mechanisms.

Other names

Vitamin B6 metabolismPyridoxine metabolismPLP-dependent enzymatic pathways

For drugs like pyridoxine/PLP supplementation: - Acts as cofactor replacement therapy for deficient enzymatic activity. For inhibitors like isoniazid: - Inhibits conversion of vitamin B6 to its active form or increases excretion/metabolism leading to functional deficiency.